Compare BridgeBio Pharma Inc (BBIO) vs VNET Group Inc (VNET) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs VNET Group Inc — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while VNET Group Inc trades at $7.51 (market cap $2.14B). The key difference: BridgeBio Pharma Inc is far larger — about 7.6× VNET Group Inc's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, VNET Group Inc nearer its low. Which is the better fit depends on your goals.
| BBIO | VNET | |
|---|---|---|
Market Cap | $16.36B | $2.14B |
Sector | Health | Technology |
52-Week High | $90.17 | $14.03 |
52-Week Low | $47.29 | $6.29 |
Enterprise Value | $18.14B | $5.29B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About VNET Group Inc
VNET Group, formerly 21Vianet, is a leading carrier-neutral data center services provider in China. It operates a dual-core strategy: a large-scale retail business serving over 7,000 enterprise customers and an aggressive wholesale segment (Hyperscale 2.0) designed to meet the high-density power and cooling demands of large-scale AI and cloud platforms.
Read more on VNET →
